DRG:HYBRID-XL and Vitamin D 25-OH Assay Used in Major Study in Poland Linking Vitamin D Deficiency to Patients with Myocardial Infarction!

Mar 17, 2014Products

The DRG:HYBRiD.XL has been used in Poland along with the DRG Vitamin D 25-OH (HYE5334) assay to determine valuable findings in the cardiovascular realm. The Polish Heart Journal recently reported the study “Seasonal effect of vitamin D deficiency in patients with acute myocardial infarction,” authored by Stepien et al. The authors used the DRG Vitamin D 25-OH assay to measure Vitamin D deficiency in subjects with heart problems.

Vitamin D is a prohormone that has long been known for its important role in regulating body levels of calcium and phosphorous and in mineralization of bone. Vitamin D plays a vital role in the formation and maintenance of strong healthy bones. However, in recent years, Vitamin D has become an assay of general health status, and there have been multiple publications linking vitamin D to several disease states such as cancer, cardiovascular disease, diabetes and autoimmune disease.


To learn more about DRG’s Vitamin D 25-OH product in both manual ELISA format as well as the automated Hybird-XL parameter, please contact DRG today! A special discount is now being given for purchases of Vitamin D 25-OH EIA5396 and HYE5334. Please call +1-973-564-7555 or email [email protected] to inquire about this Vitamin D 25-OH discount.

Vitamin D Publication Kardiologia CLICK HERE


News and Updates

Click the link to learn more about how DRG is certified in the manufacturing and distribution of in-vitro diagnostic reagents used in the diagnosis of autoimmune status, cancer, cardiac markers, disease status, fertility testing, pregnancy testing, diabetes and immune status.